胸腔镜下亚肺叶切除与肺叶切除治疗IA期非小细胞肺癌疗效分析  

The effect of VATS Sub-pulmonary Lobectomy and Pulmonary Lobectomy for the treatment of non-small cell lung cancer in IA stage

作　　者：王鑫[1] 朱光[1] 高兴才[1] 罗坤[1] 

机构地区：[1]郑州大学第五附属医院心胸外科,河南郑州450052

出　　处：《当代医学》2018年第4期39-41,共3页Contemporary Medicine

摘　　要：目的分析胸腔镜下亚肺叶切除术治疗IA期非小细胞肺癌的围手术期临床效果,为IA期非小细胞肺癌患者的外科治疗提供临床依据。方法回顾性分析2013年1月~2016年1月本院心胸外科收治的75例IA期非小细胞肺癌患者的临床资料,胸腔镜下亚肺叶切除术组36例;肺叶切除术组39例。比较两组患者年龄、手术时间、术中出血量、术后卧床时间、胸管引流时间、术后首日胸液引流量、术后住院时间、术前合并症例数、术后并发症发生率。结果胸腔镜下亚肺叶切除组与肺叶切除组术后并发症发生率、术后首日胸液引流量和术后住院时间比较差异均无统计学意义。与肺叶切除组比较,亚肺叶切除组患者年龄较大,且术前合并症较多,手术时间短,术中出血量少,术后卧床时间短,术后胸管引流时间短,差异有统计学意义(P<0.05)。两组患者在围手术期均无死亡。结论胸腔镜下亚肺叶切除术与肺叶切除术治疗IA期非小细胞肺癌围手术期内均安全有效,但胸腔镜下亚肺叶切除术对于术前合并基础疾病、年龄较大的非小细胞肺癌患者更有优势,且创伤小,术中出血少,术后卧床时间短,更有利于患者术后快速康复,值得在临床上推广应用。Objective To analyze the thoracoscopic sub-pulmonary lobectomy for the treatment of stage IA non-small cell lung cancer perioperative clinical effect, providing clinical basis for surgical treatment of patients with stage IA non-small cell lung cancer. Methods A retrospective analysis from January 2013 to January 2016 75 cases of clinical data of patients with stage IA non small cell lung cancer in the department of Cardio-Thoracic Surgery of our hospital, thoracoscopic sub-pulmonary lobectomy group 36 cases; lobectomy group 39 cases. Moreover, the age of patients, surgery time, amount of bleeding, postoperative bed time, chest tube drainage time, postoperative first day of thoracic drainage, postoperative hospital stay, preoperative complications cases, the incidence of postoperative complications were analyzed in the two groups. Results There were no statistically significant differences in the incidence of postoperative complications, postoperative first thoracic drainage and the postoperative hospitalization time. Compared with lobectomy group, patiens in sub-pulmonary lobectomy group were older and more preoperative complications, shorter operation time, less bleeding during the operation, shorter postoperative bed time and postoperative chest tube drainage time, the difference was statistically significant(P<0.05). The two groups had no death in perioperative period. Conclusion Both thoracoscopic sub-pulmonary lobectomy and lobectomy for stage IA non-small cell lung cancer perioperative period are safe and effective, but thoracoscopic sub-pulmonary lobectomy for more preoperative underlying diseases or older patients have more advantages, and less trauma, less bleeding, shorter postoperative bed time, more conducive to the rapid recovery of patients after surgery, it is worth popularizing in clinical.

关 键 词：亚肺叶切除术 肺叶切除术 IA期非小细胞肺癌 

分 类 号：R734.2[医药卫生—肿瘤]